A non-interventional, prospective dynamic cohort study designed to assess the epidemiology and real-life management of MM, can explore the real-life use and efficacy of aCD38-based retreatment
Latest Information Update: 29 Jan 2024
At a glance
- Drugs Daratumumab (Primary) ; Isatuximab (Primary)
- Indications Multiple myeloma
- Focus Therapeutic Use
- Acronyms EMMY
Most Recent Events
- 12 Dec 2023 Results(n=1597) presented at the 65th American Society of Hematology Annual Meeting and Exposition
- 25 Jan 2023 New trial record
- 13 Dec 2022 Results presented at the 64th American Society of Hematology Annual Meeting and Exposition